AIM ImmunoTech Inc.
AIM
$0.29
-$0.02-5.79%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.41% | 34.18% | 42.36% | 51.13% | 40.20% |
| Total Depreciation and Amortization | -14.63% | -3.75% | 4.35% | -1.20% | 3.36% |
| Total Amortization of Deferred Charges | 83.39% | 38.36% | -20.74% | 300.00% | -- |
| Total Other Non-Cash Items | 96.16% | -10.70% | -22.45% | 148.83% | 387.42% |
| Change in Net Operating Assets | -396.62% | -31.26% | 34.33% | -95.80% | -95.85% |
| Cash from Operations | 26.40% | 37.53% | 52.88% | 44.50% | 29.99% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.77% | 654.61% | 5,284.91% | 721.51% | 637.43% |
| Cash from Investing | -60.62% | 617.26% | 4,722.03% | 731.80% | 665.63% |
| Total Debt Issued | 10.00% | -90.00% | -83.82% | -100.00% | -- |
| Total Debt Repaid | -162.95% | -- | -- | -- | -- |
| Issuance of Common Stock | 761.10% | 665.94% | -35.19% | 71.29% | 83.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 121.44% | -19.20% | -38.64% | -- | -- |
| Cash from Financing | 61.20% | 56.75% | -61.26% | 33.01% | 1,228.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 134.35% | 109.98% | 82.40% | 88.07% | 82.71% |